stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Starling Oncology, Inc. Common StockSTLN
$6.837.73%0.4902

Starling Oncology, Inc. Common Stock (STLN)

Date: 2026-11-04 16:00O: 6.44H: 7.04L: 6.41C: 6.93Vol: 1.230M
Precedente Chiudi:
$6.34
Aprire:
$6.44
Volume 24 ore:
469,221
Volume relativo:
0.37
Capitalizzazione di mercato:
$696.11M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1W Prestazione:
+2.86%
1M Prestazione:
+7.56%
6M Prestazione:
0.00%
1Y Prestazione:
0.00%
Intervallo 1D:
$6.41$6.84
Intervallo di 1 settimana:
$6.19$6.85
Portata 52W:
$4.85$7.13

Profilo aziendale di Starling Oncology, Inc. Common Stock (STLN)

Nome
Starling Oncology, Inc. Common Stock
Settore
Healthcare
Telefono
-
Indirizzo
USA
Dipendente
641
X
-
Prossima data di guadagno
2026-11-05
Ultimi documenti SEC
SEC
Discussioni di STLN su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Starling Oncology, Inc. Common Stock Azioni (STLN) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-07-06IniziatoLake StreetBuy
2025-11-25IniziatoNeedhamBuy
2025-07-23IniziatoNoble Capital MarketsOutperform
2025-07-16IniziatoB. Riley SecuritiesBuy

Starling Oncology, Inc. Common Stock Azioni (STLN) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)502.73393.41324.24252.48203.00
Operating income USD (M)-36.08-60.12-77.02-81.95-45.86
Income before tax USD (M)-60.74-64.66-83.10-0.09-11.60
Income tax expense USD (M)-0.130.00-0.04-0.24-0.67
Net income USD (M)-60.61-64.66-83.070.15-10.93
Basic EPS USD/shares-0.54-0.71-0.920.00-0.16
Diluted EPS USD/shares-0.54-0.71-0.92-0.21-0.16
Basic weighted shares shares (M)92.3975.0473.7572.7966.23
Diluted weighted shares shares (M)92.3975.0473.7580.6166.23
Selling, general and administrative USD (M)105.57107.83113.85119.6983.37

Starling Oncology, Inc. Common Stock Azioni (STLN) insider trading

  • BRADFORD HIVELYAug 21 '26
    Director
    Transazione
    Proposed Sale
    Costo
    $6.54
    #Azioni
    298,853
    Valore ($)
    1,954,499
    #Azioni Totale
    0
  • Hively BradAug 21 '26
    Director
    Transazione
    Sale
    Costo
    $6.51
    #Azioni
    298,853
    Valore ($)
    1,946,310
    #Azioni Totale
    411,976
  • Chernett JoreyAug 14 '26
    10% Owner
    Transazione
    Buy
    Costo
    $6.54
    #Azioni
    12,000
    Valore ($)
    78,480
    #Azioni Totale
    10,660,858
  • Chernett JoreyJul 21 '26
    10% Owner
    Transazione
    Buy
    Costo
    $5.27
    #Azioni
    18,000
    Valore ($)
    94,860
    #Azioni Totale
    10,648,858
  • Podnos YaleJul 14 '26
    Chief Medical Officer
    Transazione
    Sale
    Costo
    $6.41
    #Azioni
    23,452
    Valore ($)
    150,340
    #Azioni Totale
    259,527
  • YALE PODNOSJul 14 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $6.25
    #Azioni
    23,452
    Valore ($)
    146,575
    #Azioni Totale
    0
  • Podnos YaleJul 14 '26
    Chief Medical Officer
    Transazione
    Option Exercise
    Costo
    $1.90
    #Azioni
    23,452
    Valore ($)
    44,567
    #Azioni Totale
    277,501
  • Chernett JoreyJul 10 '26
    10% Owner
    Transazione
    Buy
    Costo
    $5.85
    #Azioni
    15,000
    Valore ($)
    87,750
    #Azioni Totale
    10,630,858
  • Chernett JoreyJun 23 '26
    10% Owner
    Transazione
    Buy
    Costo
    $5.02
    #Azioni
    18,000
    Valore ($)
    90,360
    #Azioni Totale
    10,615,858
  • YALE PODNOSJun 08 '26
    Officer
    Transazione
    Proposed Sale
    Costo
    $4.87
    #Azioni
    23,451
    Valore ($)
    114,206
    #Azioni Totale
    0
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
BRADFORD HIVELYDirectorAug 21 '26Proposed Sale$6.54298,8531,954,4990
Hively BradDirectorAug 21 '26Sale$6.51298,8531,946,310411,976
Chernett Jorey10% OwnerAug 14 '26Buy$6.5412,00078,48010,660,858
Chernett Jorey10% OwnerJul 21 '26Buy$5.2718,00094,86010,648,858
Podnos YaleChief Medical OfficerJul 14 '26Sale$6.4123,452150,340259,527
YALE PODNOSOfficerJul 14 '26Proposed Sale$6.2523,452146,5750
Podnos YaleChief Medical OfficerJul 14 '26Option Exercise$1.9023,45244,567277,501
Chernett Jorey10% OwnerJul 10 '26Buy$5.8515,00087,75010,630,858
Chernett Jorey10% OwnerJun 23 '26Buy$5.0218,00090,36010,615,858
YALE PODNOSOfficerJun 08 '26Proposed Sale$4.8723,451114,2060

Starling Oncology, Inc. Common Stock Borsa (STLN) Ultime notizie

Nov 03, 2026
Nov 03, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 26, 2026
Oct 19, 2026
Oct 19, 2026
Oct 14, 2026
Oct 14, 2026
Oct 13, 2026
Oct 13, 2026
Oct 10, 2026
Oct 10, 2026
Oct 07, 2026
Oct 07, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Oct 01, 2026
Sep 20, 2026
Sep 20, 2026
Sep 20, 2026
Sep 20, 2026
Sep 14, 2026
Sep 14, 2026
Sep 08, 2026
Sep 08, 2026
Aug 27, 2026
Aug 27, 2026
Aug 24, 2026
Aug 24, 2026
Aug 21, 2026
Aug 21, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 17, 2026
Aug 14, 2026
Aug 14, 2026
Aug 12, 2026
Aug 12, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 08, 2026
Aug 08, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 07, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Aug 03, 2026
Jul 13, 2026
Jul 13, 2026
Jul 06, 2026
Jul 06, 2026
Jun 24, 2026
Jun 24, 2026
Mar 12, 2026
Mar 12, 2026
Nov 14, 2025
Nov 14, 2025

Simile a STLN